Chemical Name: Dehydro Rifaximin
Smiles: O=C1C(C(C2=C(/C3=N/C(/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@H]4C)=O)N(C=CC(C)=C5)C5=N2)=C6C3=O)=C(C(C)=C6O)O[C@@]1(O/C=C/[C@@H]([C@H]([C@H]4OC(C)=O)C)OC)C
Inchi: InChI=1S/C39H47NO14/c1-17-11-10-12-18(2)37(48)40-24-15-39(51-16-26(42)53-39)29-27(33(24)46)32(45)22(6)35-28(29)36(47)38(8,54-35)50-14-13-25(49-9)19(3)34(52-23(7)41)21(5)31(44)20(4)30(17)43/h10-15,17,19-21,25,30-31,34,43-45H,16H2,1-9H3,(H,40,48)/b11-10-,14-13-,18-12-/t17-,19+,20+,21+,25-,30-,31+,34+,38-,39?/m0/s1
Structural elucidation of the Rifaximin Ph. Eur. Impurity H
Riccardo Stradi, Donatella Nava, Marino Nebuloni, Barbara Pastura, ElenaPini
Journal of Pharmaceutical and Biomedical Analysis Volume 51, Issue 4, 11 March 2010, Pages 858-865
Structure Elucidation of Two Unknown Oxydic Degradation Impurities of Rifaximin
chao liu, chang-qin hu and shao-hong jin
Asian Journal of Chemistry; Vol. 23, No. 7 (2011), 3252-3256
Development and validation of rp-hplc method for the estimation of rifaximin in bulk and in tablet dosage form
T.sudha, P.V.hemalatha, V.R.ravikumar,r.jothi, M.radhakrishnan
Asian Journal of Pharmaceutical and Clinical Research Vol.2 Issue 4, October-December 2009
Stability Indicating HPTLC Method for Analysis of Rifaximin in Pharmaceutical Formulations and an Application to Acidic Degradation Kinetic Study
Kalpana G. Patel , Nitesh R. Jain, and Purvi A. Shah
Hindawi Publishing Corporation ISRN Analytical Chemistry Volume 2013, Article ID 613218, 9 pages